Sweden
# |
Name |
Share Price |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 51.72 |
Jan. 14, 2025 | USD 51.72 | -0.10% |
|
Sweden |
|
2 |
USD 42.37 |
Jan. 14, 2025 | USD 42.37 | 0.78% |
|
Sweden |
|
3 |
USD 32.97 |
Jan. 14, 2025 | USD 32.97 | -0.61% |
|
Sweden |
|
4 |
USD 31.10 |
Jan. 14, 2025 | USD 31.10 | 0.68% |
|
Sweden |
|
5 |
USD 28.64 |
Jan. 14, 2025 | USD 28.64 | 0.87% |
|
Sweden |
|
6 |
USD 28.08 |
Jan. 14, 2025 | USD 28.08 | 0.23% |
|
Sweden |
|
7 |
USD 26.00 |
Jan. 14, 2025 | USD 26.00 | 1.16% |
|
Sweden |
|
8 |
USD 22.17 |
Jan. 14, 2025 | USD 22.17 | -0.20% |
|
Sweden |
|
9 |
USD 20.58 |
Jan. 14, 2025 | USD 20.58 | 0.68% |
|
Sweden |
|
10 |
USD 19.07 |
Jan. 14, 2025 | USD 19.07 | 4.08% |
|
Sweden |
|
11 |
USD 18.76 |
Jan. 14, 2025 | USD 18.76 | 3.89% |
|
Sweden |
|
12 |
USD 18.25 |
Jan. 14, 2025 | USD 18.25 | 2.79% |
|
Sweden |
|
13 |
USD 17.87 |
Jan. 14, 2025 | USD 17.87 | 3.09% |
|
Sweden |
|
14 |
USD 17.18 |
Jan. 14, 2025 | USD 17.18 | 2.59% |
|
Sweden |
|
15 |
USD 16.63 |
Jan. 14, 2025 | USD 16.63 | 0.49% |
|
Sweden |
|
16 |
USD 14.61 |
Jan. 14, 2025 | USD 14.61 | 2.17% |
|
Sweden |
|
17 |
USD 12.08 |
Jan. 14, 2025 | USD 12.08 | 1.50% |
|
Sweden |
|
18 |
USD 11.98 |
Jan. 14, 2025 | USD 11.98 | -2.51% |
|
Sweden |
|
19 |
USD 10.16 |
Jan. 14, 2025 | USD 10.16 | -0.20% |
|
Sweden |
|
20 |
USD 9.75 |
Jan. 14, 2025 | USD 9.75 | -0.95% |
|
Sweden |
|
21 |
USD 8.10 |
Jan. 14, 2025 | USD 8.10 | 1.52% |
|
Sweden |
|
22 |
USD 5.68 |
Jan. 14, 2025 | USD 5.68 | 4.11% |
|
Sweden |
|
23 |
USD 5.39 |
Jan. 14, 2025 | USD 5.39 | -0.39% |
|
Sweden |
|
24 |
USD 4.99 |
Jan. 14, 2025 | USD 4.99 | 0.68% |
|
Sweden |
|
25 |
USD 4.58 |
Jan. 14, 2025 | USD 4.58 | 1.67% |
|
Sweden |
|
26 |
USD 4.07 |
Jan. 14, 2025 | USD 4.07 | -5.72% |
|
Sweden |
|
27 |
USD 3.41 |
Jan. 14, 2025 | USD 3.41 | 3.24% |
|
Sweden |
|
28 |
USD 3.33 |
Jan. 14, 2025 | USD 3.33 | 0.41% |
|
Sweden |
|
29 |
USD 3.31 |
Jan. 14, 2025 | USD 3.31 | 2.33% |
|
Sweden |
|
30 |
USD 3.30 |
Jan. 14, 2025 | USD 3.30 | 3.88% |
|
Sweden |
|
31 |
USD 3.19 |
Jan. 14, 2025 | USD 3.19 | 2.10% |
|
Sweden |
|
32 |
USD 2.91 |
Jan. 14, 2025 | USD 2.91 | -2.20% |
|
Sweden |
|
33 |
USD 2.83 |
Jan. 14, 2025 | USD 2.83 | 5.31% |
|
Sweden |
|
34 |
USD 2.74 |
Jan. 14, 2025 | USD 2.74 | 1.67% |
|
Sweden |
|
35 |
USD 2.59 |
Jan. 14, 2025 | USD 2.59 | 1.03% |
|
Sweden |
|
36 |
USD 2.57 |
Jan. 14, 2025 | USD 2.57 | -0.02% |
|
Sweden |
|
37 |
USD 2.55 |
Jan. 14, 2025 | USD 2.55 | 0.33% |
|
Sweden |
|
38 |
USD 2.19 |
Jan. 13, 2025 | USD 2.19 | 0.18% |
|
Sweden |
|
39 |
USD 2.09 |
Jan. 14, 2025 | USD 2.09 | -2.04% |
|
Sweden |
|
40 |
USD 1.88 |
Jan. 14, 2025 | USD 1.88 | 0.68% |
|
Sweden |
|
41 |
USD 1.87 |
Jan. 14, 2025 | USD 1.87 | 5.71% |
|
Sweden |
|
42 |
USD 1.76 |
Jan. 14, 2025 | USD 1.76 | 2.86% |
|
Sweden |
|
43 |
USD 1.61 |
Jan. 14, 2025 | USD 1.61 | 0.34% |
|
Sweden |
|
44 |
USD 1.60 |
Jan. 14, 2025 | USD 1.60 | -0.43% |
|
Sweden |
|
45 |
USD 1.42 |
Jan. 14, 2025 | USD 1.42 | 3.80% |
|
Sweden |
|
46 |
USD 1.41 |
Jan. 14, 2025 | USD 1.41 | -1.50% |
|
Sweden |
|
47 |
USD 1.17 |
Jan. 14, 2025 | USD 1.17 | -3.73% |
|
Sweden |
|
48 |
USD 1.01 |
Jan. 14, 2025 | USD 1.01 | -1.50% |
|
Sweden |
|
49 |
USD 1.01 |
Jan. 14, 2025 | USD 1.01 | 1.76% |
|
Sweden |
|
50 |
USD 0.97 |
Jan. 14, 2025 | USD 0.97 | -2.02% |
|
Sweden |
The Health Care company in Sweden with the highest Share Price is Camurus AB (publ) (Stockholm Stock Exchange: CAMX.ST) at USD 51.72.
The Health Care company in Sweden with the lowest Share Price is Intervacc AB (publ) (Stockholm Stock Exchange: IVACC.ST) at USD 0.08.
The top 10 Health Care companies in Sweden by Share Price are Camurus AB (publ), Xvivo Perfusion AB (publ), Bonesupport Holding AB (publ), Probi AB (publ), Swedish Orphan Biovitrum AB (publ), Lifco AB (publ), Essity AB (publ), Sectra AB (publ), RaySearch Laboratories AB (publ) and Stille AB.
The bottom 10 Health Care companies in Sweden by Share Price are Intervacc AB (publ), Ellen AB (publ), Kancera AB (publ), Aptahem AB (publ), AlzeCure Pharma AB (publ), aXichem AB, BrainCool AB (publ), Oncopeptides AB (publ), Scandinavian ChemoTech AB (publ) and Modus Therapeutics Holding AB (publ).